Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Miller

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
BMJ Open|April 2, 2022
Learning from alcohol (policy) reforms in the Northern Territory (LEARNT): protocol for a mixed-methods study examining the impacts of the banned drinker registerPeter Miller, Kerri Coomber, James Smith, et al.
Australian and New Zealand Journal of Public Health|September 19, 2022
Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre studyPeter Miller, Thea Vakidis, Nicholas Taylor, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Emergency Medicine Australasia : EMA|March 16, 2019
Driving change: A partnership study protocol using shared emergency department data to reduce alcohol-related harmPeter Miller, Nicolas Droste, Diana Egerton-Warburton, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
BMJ Open|April 2, 2022
Learning from alcohol (policy) reforms in the Northern Territory (LEARNT): protocol for a mixed-methods study examining the impacts of the banned drinker registerPeter Miller, Kerri Coomber, James Smith, et al.
Australian and New Zealand Journal of Public Health|September 19, 2022
Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre studyPeter Miller, Thea Vakidis, Nicholas Taylor, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 21